Dr. Thomas Fellner is the Global Business Head for Cell Therapy at Lonza, Inc.  Lonza is a Swiss company with a strong focus on process development and contract manufacturing of therapeutic materials including small molecules, biologics and cells. In his current role Dr. Fellner has the global business responsibility for Lonza’s Cell Therapy setup including US, Singapore and Japan. Prior to his current role, he was the Director of Business Development for Cell Therapy developing and executing business and sales strategies for Lonza’s Cell Therapy Business to ensure market leadership and expansion into new markets.  Dr. Fellner was also an integral part of establishing Lonza’s pluripotent stem cell platform and leading a program to develop technologies that enable the manufacture of the world’s first clinical-grade induced pluripotent stem cell line.  Dr. Fellner holds a Ph.D. degree from the University of Vienna, Austria and a M.B.A degree in Entrepreneurship from the University of California in San Diego.